Navin Fluorine International Limited has informed the Exchange about Transcript
NAVINFLUOR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Navin Fluorine reported a strong Q3 FY26 with consolidated revenue of Rs.892 crores, up 47% year-on-year and 18% sequentially, driven by growth across all three verticals. Nine-month revenue reached Rs.2,376 crores (+44%), already surpassing the full FY25 revenue. Operating EBITDA jumped 109% YoY to Rs.308 crores with margin expanding to 34.5% from 24.3%, while nine-month EBITDA margin stood at 32% versus 21.5% last year. PAT for the quarter grew 122% YoY to Rs.185 crores. HPP revenue rose 35% to Rs.412 crores with R-32 utilization at 100%, Specialty Chemicals hit its highest-ever quarterly revenue of Rs.354 crores (+60% YoY), and CDMO grew 61% to Rs.127 crores. The company commissioned its cGMP-4 Phase-1 facility and AHF project during the quarter, marking the end of Wave-1 capex, while Wave-2 projects (Chemours, MPP debottlenecking, R-32 expansion) are on track for FY27. Net debt-to-equity remains very low at 0.03x and working capital is below 80 days.
The CFO has guided to a sustainable ~30% annualised EBITDA margin (versus prior ~25% guidance), with the company inching closer to its $100 million CDMO aspirational target. Strong order visibility across all verticals, completed capex commissioning, and a near-debt-free balance sheet point to sustained growth momentum and potential for positive stock sentiment.